Vevye: A New Cyclosporine Solution for Dry Eye Disease
XTalks
JUNE 14, 2023
Sheppard, MD, MMSc, FACS, professor of ophthalmology at Eastern Virginia Medical School, and mid-atlantic medical director for Eye Care Partners and investigator in the development program. Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology.
97 
Let's personalize your content